Analysis
A cluster of China's biggest AI labs is racing toward public markets within months of each other, in one of the most compressed waves of sector-specific IPO activity anywhere in tech this year. Moonshot AI is preparing a Hong Kong listing within roughly six months at a valuation of up to $50 billion, while DeepSeek is targeting a Shanghai STAR Market listing at up to $71 billion as soon as the second quarter of 2027. MiniMax and Z.ai have already completed Hong Kong exchange debuts back in January, meaning at least four major Chinese AI labs are now public or actively preparing to go public within the same calendar year.
The capital backing this wave is enormous even before any of it hits public markets: DeepSeek raised $7.4 billion in a single round in June, with founder Liang Wenfeng -- who also runs the High-Flyer hedge fund -- personally committing roughly $3 billion of that total. That kind of founder-level conviction capital, on top of institutional rounds, reflects how much confidence exists in the category even as Western investors remain divided on how to value open-weight Chinese models relative to closed Western frontier labs.
The strategic logic behind the compressed timing is straightforward: Kimi K3's release, which topped a major coding leaderboard, and DeepSeek's earlier demonstration that frontier-level capability could be trained far more cheaply than Western labs assumed, have together reset how global investors price the entire Chinese AI sector. Each lab has both a proof point and a narrow window in which to capitalize on it, and public markets historically reward companies that list into peak enthusiasm rather than after it has already faded.
For global AI investors, the wave raises a genuine allocation question: whether capital chasing Chinese AI IPOs represents a durable repricing of the sector's fundamentals, or a momentum trade tied to a specific news cycle that could reverse as quickly as it built, especially given how sensitive Chinese tech listings have historically been to geopolitical and regulatory shifts.
What to watch: whether Moonshot and DeepSeek's IPOs price at or near their targeted valuations once they formally launch, how MiniMax and Z.ai's stocks have performed since their January debuts as a leading indicator for the rest of the cohort, and whether any US or Chinese regulatory action intervenes in the listing timeline for either Moonshot or DeepSeek.
